500
Participants
Start Date
September 30, 2024
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Metformin
Insulin Sensitizer
Dapagliflozin
Sodium-Glucose Co-transporter-2
Dapagliflozin/Metformin
Anti diabetic drug
Letrozole
Aromataze inhibitor
Beni-suef university Hospital, Banī Suwayf
Beni-Suef University
OTHER